Table 1.
Cohort 1 | Cohort 2 | Cohort 3 | |
---|---|---|---|
Booster HMFG1 dose (mg) | 0.5 | 1 | 5 |
Number of patients | 8 | 6 | 12 |
Mean age | 58 | 48 | 49 |
Priming route (numbers i.v.:i.p.) | 4:4 | 3:3 | 4:8 |
Number completing the regimen | 4 | 1 | 8 |
Disease characteristics | |||
Pathological 2nd complete remission | 1 | 0 | 3 |
Microscopic disease | 0 | 1 | 2 |
Residual disease <0.5 cm | 4 | 2 | 3 |
Residual disease >0.5 cm | 3 | 3 | 4 |